Moderna highlights 6-month antibody persistence of its COVID-19 vaccine

By The Science Advisory Board staff writers

April 8, 2021 -- Antibody persistence lasted through six months following the second dose of Moderna's COVID-19 vaccine, according to a study published April 6 in the New England Journal of Medicine.

The study analyzed 33 healthy adult participants in the U.S. National Institute of Health-led phase I study of Moderna's COVID-19 vaccine at six months following a second 100 µg dose (day 209). Antibody decay was estimated using two approaches and was consistent with published observations of convalescent patients with COVID-19 through eight months after symptom onset, the company said in a statement.

Studies monitoring immune responses beyond six months are ongoing. Out of an abundance of caution, Moderna is also pursuing a clinical development strategy against emerging variants.

Additionally, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), will conduct a phase I clinical trial to assess the company's monovalent and multivalent modified mRNA-1273 vaccines as a primary series in naive individuals and as a booster vaccine in those previously vaccine with mRNA-1273.

Copyright © 2021

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for

Email Preferences

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.